Computational Study of Bis-(1-(Benzoyl)-3-Methyl Thiourea) Platinum (II) Complex Derivatives as Anticancer Candidates

References

• Kerr DJ, Baumann M. Oxford Textbook of Oncology. 3rd ed. United Kingdom: Oxford University Press; 2016.
   Google Scholar
• Weinberg RA. The Biology of Cancer. 2nd ed. New York: Garland Science; 2014.
   Google Scholar
• World Health Organization. Cancer. World Health Organization.
   Google Scholar
• Hacker M. Adverse drug reactions. In: Pharmacology. Academic Press; 2009:327–352.
   Google Scholar
• Dilruba S, Kalayda GV. Platinum-based drugs: past, present and future. Cancer Chemother Pharmacol. 2016;77(6):1103–1124. doi:10.1007/s00280-016-2976-z
   PubMed Web of Science ®Google Scholar
• Popławska B, Bielawska A, Surazyński A, Czarnomysy R, Bielawski K. Novel dinuclear platinum(II) complexes targets NFkappaB signaling pathway to induce apoptosis and inhibit metabolism of MCF-7 breast cancer cells. Folia Histochem Cytobiol. 2009;47(5):S141–146. doi:10.2478/v10042-009-0084-1
   PubMed Web of Science ®Google Scholar
• Czarnomysy R, Bielawska A, Muszyńska A, Bielawski K. Effects of novel alkyl pyridine platinum complexes on apoptosis in Ishikawa endometrial cancer cells. Med Chem. 2015;11(6):540–550. doi:10.2174/1573406411666150206163547
   PubMed Web of Science ®Google Scholar
• Bielawski K, Czarnomysy R, Muszyńska A, Bielawska A, Popławska B. Cytotoxicity and induction of apoptosis of human breast cancer cells by novel platinum(II) complexes. Environ Toxicol Pharmacol. 2013;35(2):254–264. doi:10.1016/j.etap.2012.12.010
   PubMed Web of Science ®Google Scholar
• Czarnomysy R, Bielawski K, Muszynska A, Bielawska A, Gornowicz A. Biological evaluation of dimethylpyridine–platinum complexes with potent antiproliferative activity. J Enzyme Inhib Med Chem. 2016;31(sup3):150–165. doi:10.1080/14756366.2016.1212191
   PubMed Web of Science ®Google Scholar
• Kirishnamaline G, Magdaline JD, Chithambarathanu T, Aruldhas D, Anuf AR. Theoretical investigation of structure, anticancer activity and molecular docking of thiourea derivatives. J Mol Struct. 2021;1225. doi:10.1016/j.molstruc.2020.129118
   Google Scholar
• Ghorab MM, Alsaid MS, El-Gaby MSA, Elaasser MM, Nissan YM. Antimicrobial and anticancer activity of some novel fluorinated thiourea derivatives carrying sulfonamide moieties: synthesis, biological evaluation and molecular docking. Chem Cent J. 2017;11(1):1–14. doi:10.1186/s13065-017-0258-4
   PubMedGoogle Scholar
• Miftah AM, Tjahjono DH. Synthesis and in vitro cytotoxicity of 1-benzoyl-3-methyl thiourea derivatives. Procedia Chem. 2015;17:157–161. doi:10.1016/j.proche.2015.12.105
   Google Scholar
• Fuks L, Anuszewska E, Kruszewska H, Krówczyński A, Dudek J, Sadlej-Sosnowska N. Platinum(II) complexes with thiourea derivatives containing oxygen, sulfur or selenium in a heterocyclic ring: computational studies and cytotoxic properties. Transit Met Chem. 2010;35(6):639–647. doi:10.1007/s11243-010-9375-9
   Web of Science ®Google Scholar
• Ruswanto R. Molecular docking of four isonicotinohydrazide derivatives in mycobacterium tuberculosis enoyl-acyl carrier protein reductase (InhA). J Kesehat Bakti Tunas Husada. 2015;13(1):135–141. doi:10.36465/jkbth.v13i1.25
   Google Scholar
• Ruswanto R, Nofianti T, Mardianingrum R, Lestari T. Design and in silico study of kuwanon-H derivative compounds as anti-HIV drug candidates. J Kim Val. 2018;4(1):57–66. doi:10.15408/jkv.v4i1.6867
   Google Scholar
• Victory A, Syahdi RR, Yanuar A. Virtual screening of Indonesian herbal database as murine double minute-2 (MDM2) inhibitor. Pharmacogn J. 2018;10(6):1184–1189. doi:10.5530/pj.2018.6.203
   Google Scholar
• Puratchikody A, Sriram D, Umamaheswari A, Irfan N. D structural interactions and quantitative structural toxicity studies of tyrosine derivatives intended for safe potent inflammation treatment. Chem Cent J. 2016;10:1–19. doi:10.1186/s13065-016-0169-9
   PubMedGoogle Scholar
• Ruswanto R, Miftah AM, Tjahjono DH. In silico study of 1-benzoyl-3-methylthiourea derivatives activity as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor candidates. Chem Data Collect. 2021;34:100741. doi:10.1016/j.cdc.2021.100741
   Google Scholar
• Tripathi A, Shrinet K, Singh VK, Kumar A. Molecular modelling and docking of mus musculus HMGB1 Inflammatory protein with CGA. Bioinformation. 2019;15(7):456–466. doi:10.6026/97320630015456
   PubMed Web of Science ®Google Scholar
• Ruswanto R, Nofianti T, Mardianingrum R, Kesuma D. Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment. Heliyon. 2022;8:e10694. doi:10.1016/j.heliyon.2022.e10694
   PubMed Web of Science ®Google Scholar
• Chintha C, Carlesso A, Gorman AM, Samali A, Eriksson LA. Molecular modeling provides a structural basis for PERK inhibitor selectivity towards RIPK1. RSC Adv. 2019;10(1):367–375. doi:10.1039/c9ra08047c
   PubMed Web of Science ®Google Scholar
• Blessy JJ, Sharmila DJS. Molecular simulation of N-acetylneuraminic acid analogs and molecular dynamics studies of cholera toxin-neu5gc complex. J Biomol Struct Dyn. 2015;33(5):1126–1139. doi:10.1080/07391102.2014.931825
   PubMed Web of Science ®Google Scholar
• Shankar U, Kumar A, Shankar U. Discovery of new hydroxyethylamine analogs against 3CL pro protein target of SARS-CoV-2: molecular docking, molecular dynamics simulation, and structure–activity relationship studies. J Chem Inf Model. 2020;60(12):5754–5770. doi:10.1021/acs.jcim.0c00326
   PubMed Web of Science ®Google Scholar
• Pires DEV, Blundell TL, Ascher DB. PkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066–4072. doi:10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Ruswanto R, Garna IM, Tuslinah L, Mardianingrum R, Lestari T, Nofianti T. Quercetin, an inhibitor of uridine 5-monophosphate synthase as an anti-cancer candidate. ALCHEMY J Penelit Kim. 2018;14(2):236. doi:10.20961/alchemy.14.2.14396.236-254
   Google Scholar
• Gaffar S, Masyhuri AA, Hartati YW, Rustaman R. In silico study of single chain variable fragment (SCFV) Selective for basic natriuretic peptide (BNP) hormone. Chim Nat Acta. 2016;4(2):52. doi:10.24198/cna.v4.n2.10671
   Google Scholar
• Hasan R, Rony MNH, Ahmed R. In silico characterization and structural modeling of bacterial metalloprotease of family M4. J Genet Eng Biotechnol. 2021;19(1). doi:10.1186/s43141-020-00105-y
   Web of Science ®Google Scholar
• Lemmon G, Meiler J. Towards ligand docking including explicit interface water molecules. PLoS One. 2013;8(6):1–12. doi:10.1371/journal.pone.0067536
   Web of Science ®Google Scholar
• Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27(3):221–234. doi:10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Kolina J, Sumiwi SA, Levita J. Linkage mode of secondary metabolites in yellow root plants (arcangelisia flava L.) with nitric oxide synthase. FITOFARMAKA J Ilm Farm. 2019;8(1):45–52. doi:10.33751/jf.v8i1.1171
   Google Scholar
• Sari IW, Junaidin J, Pratiwi D. Molecular docking study of the flavonoid compound of orthosiphon stamineus b.) on α-glucosidase receptors as anti-diabetic type 2. J Farmagazine. 2020;7(2):54. doi:10.47653/farm.v7i2.194
   Google Scholar
• Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein–ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016;11(5):905–919. doi:10.1038/nprot.2016.051
   PubMed Web of Science ®Google Scholar
• Arwansyah A, Ambarsari L, Sumaryada TI. Docking simulation of curcumin and its analogues as androgen receptor inhibitors in prostate cancer. Curr Biochem. 2014;1(1):11–19. doi:10.29244/cb.1.1.11-19
   Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;2001:24.
   Google Scholar
• Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1(4):337–341. doi:10.1016/j.ddtec.2004.11.007
   PubMedGoogle Scholar
• Suhadi A, Rizarullah R, Feriyani F. Docking simulation of the active compound of binahong leaves as an aldose reductase enzyme inhibitor. Sel J Penelit Kesehat. 2019;6(2):55–65. doi:10.22435/sel.v6i2.1651
   Google Scholar
• Tambunan USF, Amri N, Parikesit AA. Silico design of cyclic peptides as influenza virus, a subtype H1N1 neuraminidase inhibitor. Afr J Biotechnol. 2012;11(52):11474–11491. doi:10.5897/ajb11.4094
   Google Scholar
• Rachmania RA, Supandi S, Larasati OA. In-silico analysis of the diterpenoid lactone compound of Sambiloto herb (Andrographis Paniculata Nees) on alpha-glucosidase receptors as anti-diabetic type II. PHARMACY. 2015;12(2):210–222.
   Google Scholar
• Mardiana M. Molecular dynamics simulation of pyridine compounds on 2XNB protein as anticancer using Gromacs applications. J Min Inst Jpn. 2019;81(922):235–236.
   Google Scholar
• Fatriansyah JF, Rizqillah RK, Yandi MY, Sahlan M, Sahlan M. Molecular docking and dynamics studies on propolis sulabiroin-A as a potential inhibitor of SARS-CoV-2. J King Saud Univ Sci. 2022;34(1):101707. doi:10.1016/j.jksus.2021.101707
   PubMed Web of Science ®Google Scholar
• Shiau AK, Barstad D, Loria PM, et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 1998;95(7):927–937. doi:10.1016/S0092-8674(00)81717-1
   PubMed Web of Science ®Google Scholar
• Bohl CE, Gao W, Miller DD, Bell CE, Dalton JT. Structural basis for antagonism and resistance of bicalutamide in prostate cancer. Proc Natl Acad Sci. 2005;102(17):6201–6206. doi:10.1073/pnas.0500381102
   PubMed Web of Science ®Google Scholar
• Yun C-H, Boggon TJ, Li Y, et al. Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: mechanism of Activation and Insights into Differential Inhibitor Sensitivity. Cancer Cell. 2007;11(3):217–227. doi:10.1016/j.ccr.2006.12.017
   PubMed Web of Science ®Google Scholar